RXSIGHT INC. - COMMON STOCK

RxSight, Inc. Announces Preliminary Unaudited Fourth Quarter and Full Year 2021 Financial and Operational Results

09 Jan 2022 15:00:00 By Nasdaq GlobeNewswire

RxSight, Inc. Appoints Dr. Tamara R. Fountain, M.D. and Shweta Singh Maniar to its Board of Directors

04 Jan 2022 15:05:00 By Nasdaq GlobeNewswire

RxSight to Present at the J.P. Morgan Healthcare Conference

28 Dec 2021 15:05:00 By Nasdaq GlobeNewswire

RxSight to Participate in the Ophthalmology Day at BTIG

18 Nov 2021 15:05:00 By Nasdaq GlobeNewswire

RxSight Reports Third Quarter 2021 Financial Results

10 Nov 2021 15:05:01 By Nasdaq GlobeNewswire

RxSight to Report Third Quarter 2021 Financial Results on November 10, 2021

27 Oct 2021 15:05:01 By Nasdaq GlobeNewswire

RxSight Reports Second Quarter 2021 Financial Results

09 Sep 2021 15:05:00 By Nasdaq GlobeNewswire

RxSight Announces Updated Date for Reporting Second Quarter 2021 Financial Results on September 9, 2021

01 Sep 2021 07:00:03 By Nasdaq GlobeNewswire

RxSight to Participate in the Wells Fargo Healthcare Conference

31 Aug 2021 07:00:01 By Nasdaq GlobeNewswire

RxSight to Report Second Quarter 2021 Financial Results on September 7, 2021 

24 Aug 2021 15:05:00 By Nasdaq GlobeNewswire

RxSight, Inc. Expands Commercial Leadership with Addition of Steve Everly as Vice-President of U.S. Sales

17 Aug 2021 15:05:00 By Nasdaq GlobeNewswire

RxSight Announces Appointments to its Board of Directors

10 Aug 2021 19:05:38 By Nasdaq GlobeNewswire

RxSight, Inc. Announces Closing of Initial Public Offering and Partial Exercise of the Underwriters’ Option to Purchase Additional Shares

04 Aug 2021 15:05:01 By Nasdaq GlobeNewswire